Zacks Research Downgrades Roche (OTCMKTS:RHHBY) to Strong Sell

Roche (OTCMKTS:RHHBY) was downgraded by Zacks Research from a “hold” rating to a “strong sell” rating in a note issued to investors on Tuesday,Zacks.com reports.

A number of other equities analysts have also issued reports on the stock. Argus upgraded shares of Roche from a “hold” rating to a “buy” rating in a research report on Monday, April 6th. Morgan Stanley raised shares of Roche from an “underweight” rating to an “equal weight” rating and set a $46.00 price target for the company in a research note on Friday, April 24th. Finally, HSBC cut shares of Roche from a “buy” rating to a “hold” rating in a report on Monday, July 6th. Four analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, Roche currently has a consensus rating of “Hold” and a consensus target price of $51.50.

Roche Trading Up 2.0%

Shares of Roche stock opened at $51.18 on Tuesday. The company has a quick ratio of 1.12, a current ratio of 1.38 and a debt-to-equity ratio of 0.72. Roche has a 1-year low of $37.51 and a 1-year high of $60.85. The business’s fifty day moving average price is $51.32 and its two-hundred day moving average price is $52.69.

Institutional Investors Weigh In On Roche

Hedge funds and other institutional investors have recently bought and sold shares of the business. OLD National Bancorp IN lifted its holdings in Roche by 0.7% in the 1st quarter. OLD National Bancorp IN now owns 257,854 shares of the company’s stock valued at $12,623,000 after acquiring an additional 1,732 shares during the last quarter. S&CO Inc. grew its stake in shares of Roche by 163.0% in the 1st quarter. S&CO Inc. now owns 140,551 shares of the company’s stock worth $6,880,000 after purchasing an additional 87,107 shares during the last quarter. Opal Capital LLC bought a new stake in shares of Roche in the 1st quarter worth approximately $4,448,000. Meritage Portfolio Management bought a new stake in shares of Roche in the 4th quarter worth approximately $4,372,000. Finally, Hantz Financial Services Inc. lifted its stake in Roche by 164.9% during the fourth quarter. Hantz Financial Services Inc. now owns 79,732 shares of the company’s stock valued at $4,112,000 after purchasing an additional 49,633 shares during the last quarter.

About Roche

Roche Holding AG is a Swiss multinational healthcare company headquartered in Basel, founded in 1896 by Fritz Hoffmann‑La Roche. The company operates primarily through two complementary divisions — Pharmaceuticals and Diagnostics — and is known for integrating drug development with diagnostic capabilities to advance personalized healthcare. In the United States and other international markets, shares trade as American Depositary Receipts under the ticker RHHBY (OTCMKTS:RHHBY).

In pharmaceuticals, Roche focuses on developing and commercializing prescription medicines across therapeutic areas including oncology, immunology, infectious diseases and neuroscience, with a notable emphasis on targeted biologics and personalized therapies.